Accustem Sciences Inc. (ACUT)
2025-06-30 | ||||
|---|---|---|---|---|
| Research and development expenses | 60,204 | |||
| General and administrative expenses | 341,199 | |||
| Total operating expenses | 401,403 | |||
| Loss from operations | -401,403 | |||
| Loss, before tax | -401,403 | |||
| Net loss | -401,403 | |||
| Net loss per share attributable to common stockholders, basic | -0.02 | |||
| Net loss per share attributable to common stockholders, diluted | -0.02 | |||
| Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, basic | 16,072,267 | |||
| Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted | 16,072,267 | |||